| DB ID | MyCo_3919 |
| Title | Evaluation of serum levels of carcinoembryonic antigen in allergic bronchopulmonary aspergillosis |
| Year | 2013 |
| PMID | 24419710 |
| Fungal Diseases involved | Allergic bronchopulmonary aspergillosis |
| Associated Medical Condition | None |
| Genus | Aspergillus |
| Species | spp. |
| Organism | Aspergillus spp. |
| Ethical Statement | None |
| Site of Infection | None |
| Opportunistic invasive | None |
| Sample type | Body fluid |
| Sample source | Serum |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | CEA |
| Biomarker Full Name | CarcinoembryonicAntigen |
| Biomarker Type | Diagnostic |
| Biomolecule | Protein |
| Geographical Location | Japan |
| Cohort | The subjects were 13 patients (6 men and 7 women aged 34 to76 years) who had been treated for ABPA at our hospital, SaitamaMedicalUniversity. |
| Cohort No. | 13 |
| Age Group | 34-76 |
| P Value | None |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Technique | Immunological assay |
| Analysis Method | Immunoenzymometric assay |
| ELISA kits | None |
| Assay Data | immunoenzymometric assay (ST AIA-PACK CEA, TosohCorp.,Tokyo,Japan). |
| Validation Techniques used | Immunoenzymometric assay |
| Up Regulation Down Regulation | Increase |
| Sequence Data | None |
| External Link | None |
